<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04604847</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL19_0192</org_study_id>
    <nct_id>NCT04604847</nct_id>
  </id_info>
  <brief_title>Postoperative Painful Chronicization After Knee Replacement Surgery : Exploratory Study of BDNF's Kinetics</brief_title>
  <acronym>KNEE BDNF</acronym>
  <official_title>Postoperative Painful Chronicization After Knee Replacement Surgery : Exploratory Study of BDNF's Kinetics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chronic pain is an extremely disabling disease. It is a major public health problem due to&#xD;
      the lack of effective therapy.&#xD;
&#xD;
      Chronic postoperative pain (CPOP) is defined by a painful symptomatology in the operated area&#xD;
      unrelated to previous pain, present for more than 3 months, and without any link to surgical&#xD;
      complication.&#xD;
&#xD;
      The prevalence of chronicization of postoperative pain is 30% after total knee arthroplasty.&#xD;
&#xD;
      Identification of clinical, biological and psychological profiles are crucial to prevent&#xD;
      CPOP.&#xD;
&#xD;
      A biologic factor, Brain Derived Neurotrophic Factor (BDNF) produced by a variety of cells is&#xD;
      a key regulator of neuroplasticity. BDNF is increasingly studied in the mechanisms of&#xD;
      cerebral sensitization and pain chronicization. The role of BDNF in pain of patients remains&#xD;
      to be explored in a prospective study. The aim of this observational study is to compare the&#xD;
      kinetics of BDNF after total knee arthroplasty in patients with and without CPOP.&#xD;
&#xD;
      Patients will be included in the study at the preanesthetic consultation. Serum BDNF levels&#xD;
      will be measured preoperatively, 48h postoperatively, 3 and 6 months after surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 4, 2020</start_date>
  <completion_date type="Anticipated">October 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Prospective study to analyze perioperative blood samples in patient after knee replacement surgery. Patients will be included in the study at the pre-anesthetic consultation. Serum BDNF levels will be measured preoperatively, 48h postoperatively, 3 and 6 months after surgery.</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>BDNF level</measure>
    <time_frame>preoperative to 6 months after surgery</time_frame>
    <description>assessed by ELISA technique</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain level</measure>
    <time_frame>preoperative to 6 months after surgery</time_frame>
    <description>evaluated by Visual Analog Scale (VAS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neuropathic pain diagnostic</measure>
    <time_frame>preoperative to 6 months after surgery</time_frame>
    <description>evaluated by neuropathic pain diagnostic questionnaire (DN4)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative rehabilitation</measure>
    <time_frame>preoperative to 6 months after surgery</time_frame>
    <description>evaluated by the Brief Pain Questionary (BPI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health related quality of life</measure>
    <time_frame>preoperative to 6 months after surgery</time_frame>
    <description>evaluated by the SF-12 Health Survey</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety and Depression</measure>
    <time_frame>preoperative to 6 months after surgery</time_frame>
    <description>evaluated by the Hospital Anxiety and Depression scale (HAD)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain level perception</measure>
    <time_frame>preoperative to 6 months after surgery</time_frame>
    <description>evaluated by the The pain Catastrophizing Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of functional capacities in knee arthritis</measure>
    <time_frame>preoperative to 6 months after surgery</time_frame>
    <description>evaluated by the Western Ontario and McMaster Universities Arthritis Index (WOMAC)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxidative stress marker</measure>
    <time_frame>preoperative to 6 months after surgery</time_frame>
    <description>8-iso-prostaglandin F2α level by biochemical labeling</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Total Knee Arthroplasty</condition>
  <condition>Chronic Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Total knee arthroplasty</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>patient operated for a total knee arthroplasty</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>blood test</intervention_name>
    <description>blood test to explore BDNF level</description>
    <arm_group_label>Total knee arthroplasty</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Social security affiliation&#xD;
&#xD;
          -  Adult patients&#xD;
&#xD;
          -  Signed informed consent&#xD;
&#xD;
          -  Score ASA (American Society of Anesthesiology) 1-3&#xD;
&#xD;
          -  Total knee arthroplasty&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient unable to exercise consent&#xD;
&#xD;
          -  Pregnant women&#xD;
&#xD;
          -  Vulnerable people&#xD;
&#xD;
          -  Patients not included in the postoperative rehabilitation program&#xD;
&#xD;
          -  Patients unable to complete the pain assessment questionnaires&#xD;
&#xD;
          -  Chronic pain patients (other than knee arthrosis)&#xD;
&#xD;
          -  Neuropathic pain patients (beforehand)&#xD;
&#xD;
          -  Inflammatory diseases, progressive cancer, sepsis, immunosuppression known&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Xavier CAPDEVILA, MD, PhD</last_name>
    <phone>+33467338256</phone>
    <email>x-capdevila@chu-montpellier.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>François JEDRYKA</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Anesthesiology and critical care, Lapeyronie University Hospital</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xavier XC CAPDEVILA, MD, PhD</last_name>
      <phone>+33467338256</phone>
      <email>x-capdevila@chu-montpellier.fr</email>
    </contact>
    <contact_backup>
      <last_name>Sophie SB BRINGUIER-BRANCHEREAU</last_name>
      <phone>+33467338256</phone>
      <email>s-bringuierbranchereau@chu-montpellier.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Xavier XC CAPDEVILA, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>October 12, 2020</study_first_submitted>
  <study_first_submitted_qc>October 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 27, 2020</study_first_posted>
  <last_update_submitted>January 12, 2021</last_update_submitted>
  <last_update_submitted_qc>January 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Chronic Postoperative Pain</keyword>
  <keyword>Brain Derived Neurotrophic Factor</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

